Cumulative Lifetime Marijuana Use and Incident Cardiovascular Disease in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study

被引:89
作者
Reis, Jared P. [1 ]
Auer, Reto [2 ]
Bancks, Michael P. [3 ]
Goff, David C., Jr. [1 ]
Lewis, Cora E. [4 ]
Pletcher, Mark J. [5 ]
Rana, Jamal S. [6 ]
Shikany, James M. [4 ]
Sidney, Stephen [6 ]
机构
[1] NHLBI, Div Cardiovasc Sci, Bldg 10, Bethesda, MD 20892 USA
[2] Univ Bern, Inst Primary Hlth Care, Bern, Switzerland
[3] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA
[4] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL USA
[5] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[6] Kaiser Permanente Northern Calif, Div Res, 2000 Broadway, Oakland, CA 94612 USA
关键词
ACUTE MYOCARDIAL-INFARCTION; ANGINA-PECTORIS; SMOKING; ASSOCIATION; MORTALITY; STROKE; DELTA-9-TETRAHYDROCANNABINOL; MECHANISMS; MARIHUANA;
D O I
10.2105/AJPH.2017.303654
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives. To investigate the effects of marijuana in the development of incident cardiovascular and cerebrovascular outcomes. Methods. Participants were 5113 adults aged 18 to 30 years at baseline (1985-1986) from the Coronary Artery Risk Development in Young Adults study, who were followed for more than 25 years. We estimated cumulative lifetime exposure to marijuana using repeated assessments collected at examinations every 2 to 5 years. The primary outcome was incident cardiovascular disease (CVD) through 2013. Results. A total of 84% (n = 4286) reported a history of marijuana use. During a median 26.9 years (131 990 person-years), we identified 215 CVD events, including 62 strokes or transient ischemic attacks, 104 cases of coronary heart disease, and 50 CVD deaths. Compared with no marijuana use, cumulative lifetime and recent marijuana use showed no association with incident CVD, stroke or transient ischemic attacks, coronary heart disease, or CVD mortality. Marijuana use was not associated with CVD when stratified by age, gender, race, or family history of CVD. Conclusions. Neither cumulative lifetime nor recent use of marijuana is associated with the incidence of CVD in middle age.
引用
收藏
页码:601 / 606
页数:6
相关论文
共 39 条
[1]   MARIHUANA AND 2ND-DEGREE AV BLOCK [J].
AKINS, D ;
AWDEH, MR .
SOUTHERN MEDICAL JOURNAL, 1981, 74 (03) :371-373
[2]  
[Anonymous], 2014, Results from the 2013 national survey on drug use and health: summary of national findings
[3]  
ARONOW WS, 1975, CLIN PHARMACOL THER, V17, P549
[4]   EFFECT OF MARIHUANA AND PLACEBO-MARIHUANA SMOKING ON ANGINA-PECTORIS [J].
ARONOW, WS ;
CASSIDY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (02) :65-67
[5]   Association Between Lifetime Marijuana Use and Cognitive Function in Middle Age The Coronary Artery Risk Development in Young Adults (CARDIA) Study [J].
Auer, Reto ;
Vittinghoff, Eric ;
Yaffe, Kristine ;
Kuenzi, Arnaud ;
Kertesz, Stefan G. ;
Levine, Deborah A. ;
Albanese, Emiliano ;
Whitmer, Rachel A. ;
Jacobs, David R., Jr. ;
Sidney, Stephen ;
Glymour, M. Maria ;
Pletcher, Mark J. .
JAMA INTERNAL MEDICINE, 2016, 176 (03) :352-361
[6]   Marijuana use and risk of prediabetes and diabetes by middle adulthood: the Coronary Artery Risk Development in Young Adults (CARDIA) study [J].
Bancks, Michael P. ;
Pletcher, Mark J. ;
Kertesz, Stefan G. ;
Sidney, Stephen ;
Rana, Jamal S. ;
Schreiner, Pamela J. .
DIABETOLOGIA, 2015, 58 (12) :2736-2744
[7]   Cannabis, Ischemic Stroke, and Transient Ischemic Attack A Case-Control Study [J].
Barber, Peter Alan ;
Pridmore, Heidi M. ;
Krishnamurthy, Venkatesh ;
Roberts, Sally ;
Spriggs, David A. ;
Carter, Kristie N. ;
Anderson, Neil E. .
STROKE, 2013, 44 (08) :2327-2329
[8]   MARIHUANA SMOKING - CARDIOVASCULAR EFFECTS IN MAN AND POSSIBLE MECHANISMS [J].
BEACONSFIELD, P ;
GINSBURG, J ;
RAINSBURY, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (05) :209-+
[9]  
BENOWITZ NL, 1979, CLIN PHARMACOL THER, V25, P440
[10]   CARDIOVASCULAR AND METABOLIC CONSIDERATIONS IN PROLONGED CANNABINOID ADMINISTRATION IN MAN [J].
BENOWITZ, NL ;
JONES, RT .
JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (8-9) :S214-S223